Ascendis Pharmac(ASND.US)

Event Tracking

Jan10

Ascendis Pharmaceuticals anticipates 720 million euros in revenue for fiscal year 2025

05:23

Jan9

Ascendis Pharma A/S Announces 2026 Strategic Roadmap and Stock Repurchase Plan

23:02

Wedbush Maintains Buy Rating on Ascendis Pharma with Price Target Raised

16:47

Jan8

Ascendis Pharma Reports Positive COACH II Phase Trial Results

21:01

Dec12

Stifel Nicolaus Raises Ascendis Pharma Target Price

19:28

Dec9

Ascendis Pharma A/S's stock price falls short of earnings expectations

18:38

Schedules & Filings

Schedules

Filings

Nov12

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 250.54 M, Net Income -71.52 M, EPS -1.1772

Aug7

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 185 M, Net Income -45.48 M, EPS -0.7523

May1

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 109.28 M, Net Income -102.43 M, EPS -1.7066

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change